Financial statements Vasa Therapeutics
Balance sheet of Vasa Therapeutics
Company age:
Age:
6 y. 2 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of VASA THERAPEUTICS
|
Year
|
2019
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 1 794 849,54 | 1 931 709,75 | 2 345 235,30 | 8 300 802,59 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 7 636 536,64 |
| B. Current assets | 1 789 949,54 | 1 931 709,75 | 2 345 235,30 | 664 265,95 |
| C. Share capital contributions (basic funds) | 4 900,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 1 794 849,54 | 1 931 709,75 | 2 345 235,30 | 8 300 802,59 |
| A. Equity | -411 224,54 | -522 600,65 | -3 520 564,70 | 2 098 944,77 |
| B. Liabilities and provisions for liabilities | 2 206 074,08 | 2 454 310,40 | 5 865 800,00 | 6 201 857,82 |
| I. Long-term liabilities | 660 738,80 | 1 057 257,38 | 3 492 583,48 | 3 296 001,28 |
| II. Short-term liabilities | 7 882,69 | 464 921,51 | 1 232 014,13 | 2 331 110,70 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.